Translate this page into:
Letter to the Editor
doi:
10.4103/sajc.sajc_195_17
Cutaneous Hodgkin’s lymphoma
1
Department of Histopathology, Mumbai Reference Laboratory, SRL Limited, Mumbai, Maharashtra, India
*Corresponding author: Dr. Asawari Anant Ambekar. asawariaa61@gmail.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Goyal S, Biswas A, Puri T, Gupta R, Muzumder S, Julka PK. Different faces of cutaneous Hodgkin's disease. Indian J Dermatopathol Diagn Dermatol 2014;1:79-82.
- Koch K, Patel M, Pather S, Modi D. Primary cutaneous Hodgkin's lymphoma: A rare disease variant and review of the literature. J Case Rep Stud 2016;4:204.
- White RM, Patterson JW. Cutaneous involvement in Hodgkin's disease. Cancer 1985;55:1136-45.
- Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S, et al. Prognostic significance of CD20 expression in classical Hodgkin's lymphoma: A clinicopathological study of 119 cases. Clin Cancer Res 2003;9:1381-6.
- Johri N, Patne SC, Tewari M, Kumar M. Diagnostic utility of PAX5 in Hodgkin's and non-Hodgkin's lymphoma: A Study from Northern India. J Clin Diagn Res 2016;10:XC04-7.
- Desouki MM, Post GR, Cherry D, Lazarchick J. PAX-5: A valuable immunohistochemical marker in the differential diagnosis of lymphoid neoplasms. Clin Med Res 2010;8:84-8.